Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

 

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%235188%232003%23999789999.8997%23430179%23FLA%23Volume_21,_Supplement_2,_(1_June_2003)%2BMMucosal_immunisation_and_innate_immunity%3A_two_added_values_for_vaccines._Proceedings_of_the_Euroconference%2FWorkshop_%40'Novel_strategies_of_mucosal_immunisation_through_exploitation_of_mechanisms_of_innate_immunity_in_pathogen-host_interaction%2BMSiena,_6_-_9_November_2002%2BMEdited_by_D._Boraschi,_A._Tagliabue,_M._U._Martin,_R._Rappuoli&_auth=y&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6545a6e5a5134d9255731bf838656353

 

 

Go to ScienceDirect® Home Skip Main Navigation Links
 Register or Login:   Password:     Athens Login 
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile Help (Opens new window)
Issues
Vaccine
Copyright © 2003 Elsevier Science Ltd. All rights reserved

Volume 21, Supplement 2, (1 June 2003)
Mucosal immunisation and innate immunity: two added values for vaccines. Proceedings of the Euroconference/Workshop @'Novel strategies of mucosal immunisation through exploitation of mechanisms of innate immunity in pathogen-host interaction
Siena, 6 - 9 November 2002
Edited by D. Boraschi, A. Tagliabue, M. U. Martin, R. Rappuoli
   
           Selected Display Checked Docs  | E-mail Articles View:
1.
Human natural killer cell function and their interactions with dendritic cells, Pages S38-S42
Lorenzo Moretta, Guido Ferlazzo, Maria Cristina Mingari, Giovanni Melioli and Alessandro Moretta
Abstract | Full Text + Links | PDF (72 K)
 
2.
Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity, Pages S43-S47
Alberto Mantovani, Cecilia Garlanda and Barbara Bottazzi
Abstract | Full Text + Links | PDF (72 K)
 
3.
The role of Toll-like receptor 2 in microbial disease and immunity, Pages S55-S60
Lee M. Wetzler
Abstract | Full Text + Links | PDF (87 K)
 
4.
Role of complement in the control of HIV dynamics and pathogenesis, Pages S77-S82
Heribert Stoiber, Cornelia Speth and Manfred P. Dierich
Abstract | Full Text + Links | PDF (74 K)
 
5.
Vaccination strategies: An overview, Pages S83-S88
Giuseppe Del Giudice
Abstract | Full Text + Links | PDF (76 K)
 
6.
Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges, Pages S89-S95
Jan Holmgren, Cecil Czerkinsky, Kristina Eriksson and Ali Mharandi
Abstract | Full Text + Links | PDF (85 K)
 
7.
Thinking downstream to accelerate the introduction of new vaccines for developing countries, Pages S114-S115
John D. Clemens
Abstract | Full Text + Links | PDF (36 K)
 
8.
Anti-cytokine therapeutics and infections, Pages S24-S34
Charles A. Dinarello
Abstract | Full Text + Links | PDF (120 K)
 
9.
Antigen dependent and independent mechanisms that sustain serum antibody levels, Pages S35-S37
Elisabetta Traggiai, Roberto Puzone and Antonio Lanzavecchia
Abstract | Full Text + Links | PDF (113 K)
 
10.
Innate immune responses support adaptive immunity: NKT cells induce B cell activation, Pages S48-S54
Grazia Galli, Sandra Nuti, Simona Tavarini, Luisa Galli-Stampino, Claudia De Lalla, Giulia Casorati, Paolo Dellabona and Sergio Abrignani
Abstract | Full Text + Links | PDF (219 K)
 
11.
The value of vaccines, Pages S110-S113
Vega Masignani, Maria Lattanzi and Rino Rappuoli
Abstract | Full Text + Links | PDF (164 K)
 
12.
TLR-induced negative regulatory circuits: role of suppressor of cytokine signaling (SOCS) proteins in innate immunity, Pages S61-S67
Klaus Heeg and Alexander Dalpke
Abstract | Full Text + Links | PDF (194 K)
 
13.
Innate and adaptive mucosal immunity in protection against HIV infection, Pages S68-S76
Thomas Lehner
Abstract | Full Text + Links | PDF (241 K)
 
14.
Innate immunity and pathogen–host interaction, Pages S12-S23
Christelle Basset, John Holton, Rachel O'Mahony and Ivan Roitt
Abstract | Full Text + Links | PDF (291 K)
 
15.
Bacillus spores for vaccine delivery, Pages S96-S101
Marco R. Oggioni, Annalisa Ciabattini, Anna M. Cuppone and Gianni Pozzi
Abstract | Full Text + Links | PDF (126 K)
 
16.
INNAMORA, a European Workshop focussed on the mechanisms of innate immunity in pathogen–host interaction and their exploitation in novel mucosal immunisation strategies, Pages S1-S11
Diana Boraschi, Aldo Tagliabue, Michael U. Martin and Rino Rappuoli
Abstract | Full Text + Links | PDF (103 K)
 
17.
Induction of immune responses by attenuated isogenic mutant strains of Listeria monocytogenes, Pages S102-S109
Ayub Darji, Walid Mohamed, Eugen Domann and Trinad Chakraborty
Abstract | Full Text + Links | PDF (122 K)
 
18.
Novel human vaccine strategies and the 5th Framework Programme: pushing the envelope, Pages S121-S127
Aldo Tagliabue, Maria Paola Cesaroni and David J. M. Lewis
Abstract | Full Text + Links | PDF (179 K)
 
19.
The European research effort for HIV/AIDS, malaria and tuberculosis, Pages S116-S120
Donata Medaglini and Arnd Hoeveler
Abstract | Full Text + Links | PDF (179 K)
 
20.
Editorial Board/aims and Scope, Page CO2

PDF (43 K)
 
Issues
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile   Help (Opens new window)

 

Send feedback to ScienceDirect
Software and compilation © 2003 ScienceDirect. All rights reserved.
ScienceDirect® is an Elsevier Science B.V. registered trademark.


Your use of this service is governed by Terms and Conditions. Please review our Privacy Policy for details on how we protect information that you supply.

 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.